CHAO, Mark Ping,TAKIMOTO, Chris Hidemi Mizufune,VOLKMER, Jens-Peter
申请号：
AU2019218271
公开号：
AU2019218271A1
申请日:
2019.02.11
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
Disclosed is a regimen to treat a CD20+ cancer, in particular a lymphoma. The regimen involves several cycles of administration of anti-CD20 and anti-CD47 antibodies at appropriate dosage and administration intervals.
